Redmile Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-649,446
| Closed | -$2.4M | – | 79 |
|
|
2017
Q4 | $2.4M | Sell |
649,446
-1,320,523
| -67% | -$4.89M | 0.1% | 61 |
|
|
2017
Q3 | $8.06M | Sell |
1,969,969
-1,766,025
| -47% | -$7.22M | 0.4% | 47 |
|
|
2017
Q2 | $13.9M | Sell |
3,735,994
-336,430
| -8% | -$1.25M | 0.84% | 41 |
|
|
2017
Q1 | $16.9M | Buy |
+4,072,424
| New | +$16.9M | 1.09% | 35 |
|
|
2016
Q1 | – | Sell |
-388,550
| Closed | -$5.18M | – | 62 |
|
|
2015
Q4 | $5.18M | Sell |
388,550
-213,948
| -36% | -$2.85M | 0.39% | 39 |
|
|
2015
Q3 | $9.91M | Sell |
602,498
-91,648
| -13% | -$1.51M | 0.75% | 32 |
|
|
2015
Q2 | $15.6M | Buy |
+694,146
| New | +$15.6M | 1.28% | 32 |
|